NCT04686695View on ClinicalTrials.gov

Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

May 31, 2020

Conditions
Meniere Disease
Interventions
DEVICE

taVNS

taVNS was applied using a Huatuo stimulator (SDZ-IIB) developed by Suzhou manufacture of Medical Device and Material. Stimulation parameters was 1 mA of electrical current at a frequency of 20 Hz with pulse duration ≤ 1 ms, for 30min,administered twice daily.

Trial Locations (1)

Unknown

Beijing Tongren Hospital, Beijing

All Listed Sponsors
lead

Beijing Tongren Hospital

OTHER

NCT04686695 - Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease | Biotech Hunter | Biotech Hunter